SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Unity Biotechnology Q3 EPS $(0.51), Inline

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.51) per share which met the analyst consensus estimate. This is a 13.33 percent decrease over losses of $(0.45) per share from the same period last year.

Benzinga · -

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.51) per share which met the analyst consensus estimate. This is a 13.33 percent decrease over losses of $(0.45) per share from the same period last year.